The oncogenic role of ALK was first recognized with the discovery of the nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) fusion in anaplastic large cell non-Hodgkin lymphoma (ALCL) (6). This evidence concerns the gene NPM1 and anaplastic large cell lymphoma.